Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.25
+0.30 (0.97%)
Mar 24, 2026, 1:30 PM CST

Sinphar Pharmaceutical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,9445,8015,6525,6945,5604,847
Market Cap Growth
4.33%2.64%-0.75%2.41%14.71%-6.62%
Enterprise Value
6,7766,7366,5966,8806,6346,118
Last Close Price
31.2530.5028.8028.2426.7623.16
PE Ratio
16.2815.8618.5515.1824.75-
Forward PE
-21.4821.4821.4821.4821.48
PS Ratio
1.761.721.791.921.951.99
PB Ratio
1.601.561.591.681.731.58
P/TBV Ratio
1.761.711.771.881.961.86
P/FCF Ratio
15.2414.8816.016621.1219.59-
P/OCF Ratio
10.179.929.5219.2113.0735.76
EV/Sales Ratio
2.012.002.092.322.322.51
EV/EBITDA Ratio
10.0910.0412.2213.2814.8595.71
EV/EBIT Ratio
16.2516.1622.2023.8333.40-
EV/FCF Ratio
17.3817.2718.687999.4723.38-
Debt / Equity Ratio
0.420.420.540.570.600.69
Debt / EBITDA Ratio
2.322.323.523.754.2833.06
Debt / FCF Ratio
3.993.995.392261.466.74-
Net Debt / Equity Ratio
0.150.150.200.250.210.29
Net Debt / EBITDA Ratio
0.840.841.341.671.5013.91
Net Debt / FCF Ratio
1.441.442.051004.312.36-83.59
Asset Turnover
0.540.540.500.480.460.39
Inventory Turnover
2.592.592.352.222.171.86
Quick Ratio
1.691.691.301.461.361.22
Current Ratio
2.502.501.842.201.921.76
Return on Equity (ROE)
9.76%9.76%8.21%10.79%5.22%-6.59%
Return on Assets (ROA)
4.18%4.18%2.96%2.90%2.00%-1.85%
Return on Invested Capital (ROIC)
8.63%8.61%6.47%7.09%3.39%-4.53%
Return on Capital Employed (ROCE)
8.10%8.10%6.10%5.70%4.20%-3.90%
Earnings Yield
6.15%6.30%5.39%6.59%4.04%-0.79%
FCF Yield
6.56%6.72%6.25%0.01%5.10%-0.22%
Dividend Yield
3.08%-3.31%3.12%3.30%0.76%
Payout Ratio
49.53%49.53%55.04%44.71%14.93%-
Buyback Yield / Dilution
0.04%0.04%-0.02%0.00%-0.17%-
Total Shareholder Return
3.11%0.04%3.28%3.13%3.12%0.76%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.